CEMI stock forecast
Our latest prediction for Chembio Diagnostics, Inc.'s stock price was made on the Feb. 13, 2018 when the stock price was at 7.60$.
In the short term (2weeks), CEMI's stock price should outperform the market by 2.66%. During that period the price should oscillate between -6.66% and +9.52%.
In the medium term (3months), CEMI's stock price should outperform the market by 1.18%. During that period the price should oscillate between -14.41% and +25.58%.Get email alerts
Create a solid portfolio with CEMI
About Chembio Diagnostics, Inc.
Chembio Diagnostics, Inc. develops, manufactures, markets and licenses rapid point-of-care diagnostic tests that detect infectious diseases. The firm expanding its product portfolio based upon the proprietary Dual Path Platform, which uses a small drop of blood from the fingertip to provide cost-effective diagnostic results in approximately 15 minutes. Its products include human and veterinary diagnostics. The company was founded in 1985 and is headquartered in Hauppauge, NY.
At the moment the company generates 32M USD in revenues.
On its last earning announcement, the company reported a loss of -0.50$ per share.
The book value per share is 1.55$
Three months stock forecastFeb. 13, 2018
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|